Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-24 · accession 0001882909-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-12-24 | TVTX | Calvin Sandra | SVP, CAO | S - Sale | $40.00 | -7,402 | 38.2K | -16% | -$296.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-24 | S | D | 7,402 | $40.00 | 38,233 | D | — | — |